Knowledge fractional co2 laser machine What thermal damage considerations and depth control endpoints should be observed during CO2 laser ablation of benign dermal growths? A Guide to Safe Depth Control
Author avatar

Tech Team · Belislaser

Updated 3 months ago

What thermal damage considerations and depth control endpoints should be observed during CO2 laser ablation of benign dermal growths? A Guide to Safe Depth Control


During CO2 laser ablation of benign dermal growths, the key safety principle is to control depth by visible tissue endpoints rather than by power settings alone. Use conservative energy and short exposure when precision is important, because thermal injury extends beyond the visibly vaporized tissue. The desired endpoint is a smooth contour level with the surrounding skin, while deep-root eradication in a single session should generally be avoided because it can produce permanent scarring.

Ablate only to the depth needed to flatten the lesion and restore a smooth skin contour. Reassess after each pass, avoid charring and visible fat, and account for the additional coagulation zone created by thermal diffusion.

Why Thermal Damage Must Guide Treatment

CO2 laser energy is absorbed by water

A medical CO2 laser emits at approximately 10,600 nm, a wavelength strongly absorbed by intracellular water. This rapidly heats and vaporizes tissue at the treatment surface.

The visible ablation zone is not the full extent of the injury. Heat also spreads laterally and vertically into adjacent tissue, producing a peripheral coagulation zone.

Exposure duration determines collateral injury

The thermal damage zone increases as exposure time increases. Short pulses delivered in less than approximately 1 millisecond limit heat diffusion and can produce a narrow collateral zone, reported in the supplementary reference as roughly 50–150 micrometers.

Continuous-wave treatment or longer exposures allow more heat to spread. Depending on the delivery conditions, thermal diffusion may extend substantially farther, potentially approaching 2 mm in adjacent tissue.

Lesion depth changes the risk calculation

A superficial exophytic papule may be treated by gradual vaporization and contouring. A thick or nodular lesion presents a different problem: attempting to destroy its deepest component in one session may require ablation into tissue that is more important for wound healing and cosmetic appearance.

The primary reference emphasizes that residual thermal damage may extend approximately 0.5–1.0 mm beyond the ablated zone. This margin must be included when deciding how close to the lesion base treatment should proceed.

How to Control Ablation Depth

Reassess after every pass

Wipe the treatment site after each pass to remove vaporized debris and reveal the actual tissue response. Fixed power and exposure settings cannot reliably determine depth because lesion thickness, tissue hydration, delivery mode, and treatment speed all affect the result.

A gradual pass-by-pass approach allows the clinician to stop when the appropriate anatomical endpoint is reached.

Recognize the superficial dermal endpoint

A light pink surface indicates that epidermal ablation is complete and the superficial papillary dermis has been reached. This may be an appropriate endpoint when only superficial tissue removal or contour correction is required.

At this level, continued treatment should be justified by the lesion’s residual architecture rather than by an attempt to remove every clinically hidden component.

Recognize deeper papillary dermal exposure

A yellowish, matte, “chamois leather” appearance indicates ablation into the mid-to-deep papillary dermis. This represents a deeper treatment endpoint and should be used cautiously for lesions requiring more substantial tissue removal.

The depth is not automatically appropriate for every benign growth. The expected cosmetic benefit must outweigh the additional risk of scarring and prolonged healing.

Avoid entering the reticular dermis without a clear indication

A waterlogged, cotton-thread appearance reflects exposure of deeper dermal collagen structures in the reticular dermis. This endpoint may be reserved for selected deep or resistant lesions and requires close monitoring.

For routine benign dermal growths, reaching this depth can create unnecessary permanent scarring. It should not be treated as evidence that complete root eradication is always preferable.

Stop before subcutaneous fat becomes visible

Visible yellow adipose tissue indicates that ablation has extended into subcutaneous fat. This is generally a warning that treatment has gone beyond the desired dermal plane for a superficial benign growth.

The appearance of fat should prompt immediate reassessment rather than continued vaporization.

The Desired Clinical Endpoint

Match the surrounding skin contour

The preferred endpoint is a smooth cutaneous contour that matches the adjacent normal skin. The goal is controlled reduction of the visible lesion, not maximal removal of every microscopic or deep component.

This endpoint is especially important for lesions such as trichoepitheliomas, where ablation just below the neighboring skin surface may balance cosmetic results against recurrence risk.

Balance recurrence and scarring

Ablating too shallowly may leave residual lesion tissue and result in early recurrence. Ablating too deeply increases the risk of permanent scarring because the thermal injury extends beyond the visibly removed tissue.

The correct depth is therefore pathology- and lesion-dependent. A deliberately staged or conservative approach may be safer than attempting definitive deep destruction in one treatment.

Use settings as starting points, not guarantees

Reported parameters vary by lesion and laser delivery mode. Examples in the references include low-power continuous-wave treatment around 2–5 W, with some benign growths treated around 2–3 W, and spot sizes commonly ranging from 1–3 mm.

These values should be treated as procedural starting ranges rather than universal prescriptions. Visual tissue response, exposure duration, spot size, lesion thickness, and the operator’s technique determine the actual thermal effect.

Thermal Signs That Require Caution

Charring indicates excessive heating

Charring must be avoided. It indicates slow burning at excessively high temperatures rather than clean vaporization.

Char increases unwanted lateral heat diffusion and can enlarge the wound and worsen healing. If charring appears, the clinician should reassess power, exposure duration, delivery speed, and tissue clearance.

Bleeding is not the primary depth endpoint

For some exophytic lesions, short low-power exposures can gently vaporize and shrink tissue while limiting bleeding. However, bleeding or hemostasis should not replace anatomical depth assessment.

The treatment endpoint should remain the intended tissue plane and final contour.

Collagen contraction signals deeper injury

Visible contraction of collagen bundles indicates that dermal tissue has received substantial thermal exposure. This may be expected at deeper endpoints but also signals increasing risk of scarring and delayed healing.

The response should be interpreted together with the lesion’s depth and the intended endpoint, not in isolation.

Understanding the Trade-offs

Short pulses improve precision but may reduce hemostasis

Short pulses can vaporize tissue faster than heat diffuses, reducing collateral damage. Their narrower coagulation zone may provide less hemostasis than longer or continuous exposure.

The clinician must balance precision against bleeding control without increasing exposure unnecessarily.

Continuous-wave treatment can enlarge thermal injury

Continuous-wave and longer-duration delivery may improve coagulation and hemostasis, but they also permit more heat diffusion. This can increase residual wound size, healing time, and scarring risk.

The thermal effect is therefore influenced by both total energy and how quickly that energy is delivered.

Complete clearance may not be the safest immediate goal

Deep-seated lesions can have clinically inconspicuous components beneath the visible surface. Pursuing their complete destruction in one session may require entering deeper dermal planes and can cause severe scarring.

Recurrence should be discussed in advance, particularly when the chosen endpoint deliberately prioritizes contour and tissue preservation.

Diagnostic uncertainty changes the procedure

A lesion should not be ablated solely because it appears benign if the diagnosis is uncertain. A preliminary biopsy is required when malignancy cannot be confidently excluded, since laser vaporization can destroy tissue needed for histopathological diagnosis.

CO2 laser treatment is a therapeutic procedure for an established benign diagnosis, not a substitute for diagnostic evaluation.

How to Apply This to Treatment Planning

The following principles help align depth control with the treatment objective:

  • If your primary focus is minimizing scarring: Use conservative, staged passes and stop at a smooth contour before reaching deep reticular dermis or subcutaneous fat.
  • If your primary focus is reducing recurrence: Confirm the diagnosis and lesion architecture, then balance deeper treatment against the approximately 0.5–1.0 mm peripheral thermal injury rather than pursuing the deepest root indiscriminately.
  • If your primary focus is precise ablation: Favor short exposures when clinically appropriate, wipe between passes, and use visual tissue endpoints instead of relying only on preset power.
  • If your primary focus is treating a thick or nodular lesion: Recognize that CO2 ablation alone may be insufficient or excessively injurious, and consider whether another or staged treatment strategy is more appropriate.
  • If your primary focus is procedural safety: Exclude diagnostic uncertainty, use appropriate local anesthesia, and counsel the patient about discomfort, healing, scarring, and possible recurrence.

The safest CO2 laser treatment removes enough tissue to restore the intended contour while preserving the deepest viable dermis and avoiding uncontrolled thermal spread.

Summary Table:

Endpoint Appearance Clinical Significance
Superficial dermis Light pink surface Epidermal ablation complete; safe endpoint for superficial lesions
Deep papillary dermis Yellowish, matte 'chamois leather' Deeper treatment; use cautiously, higher scar risk
Reticular dermis Waterlogged, cotton-thread Deep injury; reserve for selected cases, high scarring risk
Subcutaneous fat Visible yellow adipose tissue Warning: stop; beyond target depth for benign growths

At BELIS, we provide advanced CO2 fractional lasers designed for precise depth control, helping clinics and premium salons achieve optimal cosmetic outcomes with minimal thermal damage. Contact us now to discover how our cutting-edge aesthetic devices can enhance your practice. Get in touch with our specialists today.

Related Products

People Also Ask

Related Products

Fractional CO2 Laser Machine for Skin Treatment

Fractional CO2 Laser Machine for Skin Treatment

CO2 Fractional Laser Machine for skin rejuvenation, scar removal, and gynecological treatments. Dual-mode precision with customizable settings. Learn more now!

Fractional CO2 Laser Machine for Skin Treatment

Fractional CO2 Laser Machine for Skin Treatment

CO2 Fractional Laser Machine for skin resurfacing, scar removal & anti-aging. 40W/60W power, adjustable modes & minimal downtime. FDA-approved for safe treatments.


Leave Your Message